$5250 | Single User
$6250 | Site License
$8450 | Enterprise License

Perennial Allergic Rhinitis Market: By Treatment (Steroids, Antihistamines, Others), By Diagnosis (Radio Allergo Sorbent Testing (RAST), Blood Test, Others) & By Region-Forecast (2016-2021)
[Report Updated: 24-03-2016]

Published by Industry ARC: 24 Mar 2016 | 80304 | In Stock
Related Topics: Blood , Immunotherapy

Introduction

The rhinitis is one of the short term and environment related acute disease of the nasal system, in which irritation and inflammation of the internal lining and mucous membrane of the nose occurs. Globally, development of new and more effective products and formulations, rise in the awareness regarding perennial allergic rhinitis, increasing population of perennial allergic rhinitis patients, and environmental changes and changes in lifestyle are the prime growth drivers of global perennial allergic rhinitis market. In addition, increase in adoption of perennial allergic rhinitis treatments, and emerging economies such as China, India and others, will create new opportunities for global perennial allergic rhinitis market. However, higher cost of the research and development, and risk of side effects are the key restraints for global perennial allergic rhinitis market.

This report identifies the global perennial allergic rhinitis market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global perennial allergic rhinitis market.


Geographically Europe dominated global perennial allergic rhinitis market, because of large population of perennial allergic rhinitis patients. Asia Pacific is projected to have fastest growth, owing to rapidly increasing population, rise in consumer awareness for disease diagnosis and its treatment, modernizing healthcare infrastructure and growing medical tourism industry in developing nations such as China, and India in this region. Among all the treatment, antihistamines have the highest market share in global perennial allergic rhinitis market.

This report segments global perennial allergic rhinitis market on the basis of treatment, diagnosis, and regional market as follows:

Perennial Allergic Rhinitis Market, By Treatment: Steroids, Antihistamines, Allergen Immunotherapy Formulations, Decongestants, and Other Treatments

The report has focused study on perennial allergic rhinitis market by basis of diagnosis such as: Radio Allergo Sorbent Testing (RAST), Blood Test, Patch Test, Skin Prick Test, and Allergen Sensitivity Test

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the perennial allergic rhinitis market. Some of the major companies’ profiles in detail are as follows:

Teva Pharmaceutical Industries Ltd.

Merck & Co., Inc.

Hanmi Pharmaceuticals, Inc.

Sumitomo Pharma Co.

Hisamitsu Pharmaceutical Co.

Table of Contents
for Perennial Allergic Rhinitis Market: By Treatment (Steroids, Antihistamines, Others), By Diagnosis (Radio Allergo Sorbent Testing (RAST), Blood Test, Others) & By Region-Forecast (2016-2021) [Report Updated: 24-03-2016]

  • 1. Perennial Allergic Rhinitis Market – Market Overview

    2. Executive Summary

    3. Market Landscape

    3.1. Market Share Analysis

    3.2. Comparative Analysis

    3.3. Product Benchmarking

    3.4. End User Profiling

    3.5. Top 5 Financials Analysis

    4. Perennial Allergic Rhinitis Market– Market Forces

    4.1. Drivers

    4.1.1. Development of new and more effective products and formulations

    4.1.2. Rise in the awareness regarding perennial allergic rhinitis

    4.1.3. Increasing population of perennial allergic rhinitis patients

    4.1.4. Environmental changes and changes in lifestyle

    4.2. Restraints

    4.2.1. Higher cost of research and development

    4.2.2. Risk of side effects

    4.3. Opportunities

    4.3.1. Emerging economies

    4.3.2. Increase in adoption of perennial allergic rhinitis treatment

    4.4. Challenges

    4.5. Porter’s Five Forces Analysis

    4.5.1. Bargaining Power of Suppliers

    4.5.2. Bargaining Power of Buyers

    4.5.3. Threat of New Entrants

    4.5.4. Threat of Substitutes

    4.5.5. Degree of Competition

    5. Perennial Allergic Rhinitis Market– Strategic Analysis

    5.1. Value Chain Analysis

    5.2. Pricing Analysis

    5.3. Opportunities Analysis

    5.4. Product/Market Life Cycle Analysis

    5.5. Suppliers and Distributors

    6. Perennial Allergic Rhinitis Market, By Treatment

    6.1. Steroids

    6.2. Antihistamines

    6.3. Allergen Immunotherapy Formulations

    6.4. Decongestants

    6.5. Other Treatments

    7. Perennial Allergic Rhinitis Market, By Diagnosis

    7.1. Radio Allergo Sorbent Testing (RAST)

    7.2. Blood Test

    7.3. Patch Test

    7.4. Skin Prick Test

    7.5. Allergen Sensitivity Test

    8. Perennial Allergic Rhinitis Market, By Geography

    8.1. Europe

    8.1.1. Germany

    8.1.2. France

    8.1.3. Italy

    8.1.4. Spain

    8.1.5. Russia

    8.1.6. U.K.

    8.1.7. Rest of Europe

    8.2. Asia Pacific

    8.2.1. China

    8.2.2. India

    8.2.3. Japan

    8.2.4. South Korea

    8.2.5. Rest of Asia-Pacific

    8.3. North America

    8.3.1. U.S.

    8.3.2. Canada

    8.3.3. Mexico

    8.4. Rest of the World (RoW)

    8.4.1. Brazil

    8.4.2. Rest of RoW

    9. Perennial Allergic Rhinitis – Market Entropy

    9.1. Expansion

    9.2. Technological Developments

    9.3. Merger & Acquisitions, and Joint Ventures

    9.4. Supply- Contract

    10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

    10.1. Teva Pharmaceutical Industries Ltd.

    10.2. Merck & Co., Inc.

    10.3. Hanmi Pharmaceuticals, Inc.

    10.4. Sumitomo Pharma Co.

    10.5. Hisamitsu Pharmaceutical Co.

    10.6. Alcon Inc

    10.7. Biopharma

    10.8. Genentech, Inc.

    10.9. Pfizer, Inc.

    10.10. Novartis AG

    *More than 40 Companies are profiled in this Research Report, Complete List available on Request*

    "*Financials would be provided on a best efforts basis for private companies"

    11. Appendix

    11.1. Abbreviations

    11.2. Sources

    11.3. Research Methodology

    11.4. Bibliography

    11.5. Compilation of Expert Insights

    11.6. Disclaimer

List Of Tables
in Perennial Allergic Rhinitis Market: By Treatment (Steroids, Antihistamines, Others), By Diagnosis (Radio Allergo Sorbent Testing (RAST), Blood Test, Others) & By Region-Forecast (2016-2021) [Report Updated: 24-03-2016]

No

Additional Details

Publisher

Industry ARC

Publisher Information

IndustryARC is the Leading Provider of Market Research Reports, Custom Consulting Services, Data Analytics and Industry Analysis. Our goal is to provide the right information required by the stakeholder at the right point of time, in a format which assists an intelligent and informed decision making process!



We provide profound information with a proactive collaboration with the clients to identify new opportunities and guide them to find the best strategy for finding growth avenues. Our in-depth Research Reports with analysis done by experienced consultants and inputs from industry experts, Key Opinion Leaders (KOLs) span multiple sectors such as:

Reference

80304 | HCR 0262

Report Format

PDF

Industry ARC Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Perennial Allergic Rhinitis Drug Market Status and Outlook 2018-2025
Report SnapshotKey Content of Chapters (Including and can be customized, report is a semifinished ve...
13 Aug 2018 by 99Strategy USD $4,000 More Info
Perennial Allergic Rhinitis Global Clinical Trials Review, H1, 2018
Perennial Allergic Rhinitis Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical tria...
30 Apr 2018 by Global Data USD $2,500 More Info
Perennial Allergic Rhinitis-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,250 More Info
Perennial Allergic Rhinitis-Pipeline Insights, 2017
DelveInsight’s, “ Perennial Allergic Rhinitis-Pipeline Insights, 2017”, report provides in depth ins...
30 May 2017 by Delve Insight USD $1,250 More Info
Perennial Allergic Rhinitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Perennial Allergic Rhinitis-Global API Manufacturers, Marketed and Phase III...
30 May 2017 by Delve Insight USD $2,000 More Info
Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016
Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical tria...
30 Sep 2016 by Global Data USD $2,500 More Info

This report is published by Industry ARC

IndustryARC is the Leading Provider of Market Research Reports, Custom Consulting Services, Data Analytics and Industry Analysis. Our goal is to provide the right information required by the stakeholder at the right point of time, in a format which assists an intelligent and informed decision making process!

We provide profound information with a proactive collaboration with the clients to identify new opportunities and guide them to find the best strategy for finding growth avenues. Our in-depth Research Reports with analysis done by experienced consultants and inputs from industry experts, Key Opinion Leaders (KOLs) span multiple sectors such as:

Download Free Report Summary PDF

Perennial Allergic Rhinitis Market: By Treatment (Steroids, Antihistamines, Others), By Diagnosis (Radio Allergo Sorbent Testing (RAST), Blood Test, Others) & By Region-Forecast (2016-2021) [Report Updated: 24-03-2016] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)